Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, RxSight Inc’s stock clocked out at $14.72, down -3.41% from its previous closing price of $15.24. In other words, the price has decreased by -$3.41 from its previous closing price. On the day, 1.25 million shares were traded. RXST stock price reached its highest trading level at $15.07 during the session, while it also had its lowest trading level at $14.5.
Ratios:
To gain a deeper understanding of RXST’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.50 and its Current Ratio is at 11.36. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on April 15, 2025, initiated with a Neutral rating and assigned the stock a target price of $18.
On April 09, 2025, UBS Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $16.
JP Morgan Downgraded its Overweight to Underweight on April 04, 2025, whereas the target price for the stock was revised from $40 to $17.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fountain Tamara sold 7,000 shares for $25.71 per share. The transaction valued at 180,002 led to the insider holds 24,793 shares of the business.
TAMARA R FOUNTAIN bought 7,000 shares of RXST for $180,002 on Mar 12 ’25. On Jan 22 ’25, another insider, Maniar Shweta, who serves as the Director of the company, sold 3,519 shares for $30.87 each. As a result, the insider received 108,618 and left with 7,383 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXST now has a Market Capitalization of 597929344 and an Enterprise Value of 371093792. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.27 while its Price-to-Book (P/B) ratio in mrq is 2.12. Its current Enterprise Value per Revenue stands at 2.652 whereas that against EBITDA is -11.15.
Stock Price History:
The Beta on a monthly basis for RXST is 1.31, which has changed by -0.7531444 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, RXST has reached a high of $66.54, while it has fallen to a 52-week low of $13.50. The 50-Day Moving Average of the stock is -33.50%, while the 200-Day Moving Average is calculated to be -62.22%.
Shares Statistics:
It appears that RXST traded 830.23K shares on average per day over the past three months and 1074110 shares per day over the past ten days. A total of 40.43M shares are outstanding, with a floating share count of 38.50M. Insiders hold about 5.22% of the company’s shares, while institutions hold 91.27% stake in the company. Shares short for RXST as of 1744675200 were 3661952 with a Short Ratio of 4.41, compared to 1741910400 on 2837244. Therefore, it implies a Short% of Shares Outstanding of 3661952 and a Short% of Float of 9.47.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
